Getting to Know Nuclear Technology for More Accurate Early Cancer Detection
ABGX – Getting to Know Nuclear Technology for More Accurate Early Cancer Detection
Nuclear technology has become a breakthrough in cancer treatment, offering several advantages. According to Yustia Tuti, Chairperson of the Indonesian Society of Nuclear Medicine and Molecular Theranostics (PKN-TMI), nuclear technology involves the application of science and techniques related to energy use or materials from nuclear reactions.
“One of its applications in healthcare is the use of radiopharmaceuticals to detect, diagnose, and treat diseases, particularly cancer,” she stated in an official statement.
Dr. Yustia explained that radiopharmaceuticals contain radioactive atomic nuclei and play a crucial role in cancer diagnosis and treatment. These compounds support advanced technologies such as Positron Emission Tomography (PET Scan) and Single Photon Emission Computed Tomography (SPECT). One of the most commonly used radiopharmaceuticals in PET Scans is F18-Fluorodeoxyglucose (FDG), a glucose analog containing the radioactive isotope Fluorine-18.
“Read more : Facts about the Dangers of Nuclear Radiation and Radiation Exposure in Life“
Cancer cells, which have a high metabolism, absorb FDG more than normal cells. This process enables PET Scans to detect cancer presence and its spread with high accuracy. “The increased absorption of F18-FDG in cancer cells allows PET Scans to generate precise imaging of the cancer’s location and spread. This procedure ensures safety by using controlled radiation doses and adhering to patient safety principles,” Dr. Yustia emphasized.
To ensure the safety of PET Scan procedures, medical professionals apply three fundamental radiation safety principles:
Although PET Scans involve radioactive materials, professionals keep the procedure safe through strict supervision and measured doses.
“Read more : Music is Ariana Grande Healing Therapy from Difficult Times“
Unfortunately, Indonesia still lags behind advanced Asian countries in nuclear medicine development. However, efforts continue to improve access to high-quality healthcare through the production of radioisotopes and radiopharmaceuticals, particularly F18-FDG. Kalbe, a leading pharmaceutical company, has shown its commitment to enhancing public access to affordable and high-quality healthcare.
According to ABGX, advancements in nuclear technology are revolutionizing early cancer detection, making diagnosis more precise and treatment more effective. The adoption of nuclear medicine in Indonesia will likely expand as healthcare institutions and researchers collaborate to advance its applications.
As reported by ABGX.net, countries with developed nuclear medicine infrastructures have significantly improved early cancer diagnosis and treatment outcomes. Increased investment in nuclear medicine facilities and public awareness will help Indonesia keep pace with global advancements in this field.
By getting to know nuclear technology, more people can understand its crucial role in detecting and treating cancer early. With proper implementation and safety measures, nuclear medicine offers a promising future in the fight against cancer.